mettox
uab „credo”, j.karoso g. 21-1, lt-92136 klaipėda - imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas - veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 0.2% , veiklioji - insekticidai, akaricidai ir kitų nariuotakojų kontrolės produktai
zindan želė tarakonų, skruzdėlių ir musių naikinimui
uab ,,credo“, j. karoso g. 21-1, lt-92136 klaipėda. - imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas - veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 0.5% , veiklioji - insekticidai, akaricidai ir kitų nariuotakojų kontrolės produktai
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcinos - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. naudoti šios vakcinos turėtų būti laikantis oficialių rekomendacijų.
innovax-nd-ilt
intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologiniai vaistai - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.
bleo-cell
lex ano, uab - bleomicinas - milteliai injekciniam tirpalui - 15000 tv - bleomycin
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antinavikiniai vaistai - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
imidasect ants.
sharda europe b.v.b.a. jozef mertensstraat 142, 1702 dilbeek, belgija. - imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas - veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 0.01% , veiklioji
bros skruzdėlių gaudyklė i.
bros spółka z ograniczoną odpowiedzialnością, ul. karpia 24, pl-61-619 poznań (lenkija). - imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas; imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas - veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 0.03% , veiklioji; veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 0.03% , veiklioji
magnum gel, ec gel roaches, roaches gel, x gel roaches, roaches bait
laboratorios econovar s.l., calle muntaner 179 3º 1ª, es-08036, barselona, ispanija. - imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas - veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 2.15% , veiklioji
biopren ant gel
bábolna bioenvironmental centre private limited company, szállás u. 6, h-1107 budapest, vengrija. - imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas; imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas - veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 0.01% , veiklioji; veikliosios medžiagos cas nr.: 138261-41-3, eb nr.: 428-040-8, veikliosios medžiagos pavadinimas: imidaklopridas, 1-[[][[]](6-chlorpiridin-3-il)metil]-n-nitroimidazolidin-2-iminas, koncentracija: 0.01% , veiklioji